Aripiprazole Tablet
Product Images NDC 60687-168

34 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 60687-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp15721

Ahp15721
Aripiprazole 15 mg oral tablet, oval-shaped and light green, imprinted with "I" on one side and "15" on the other side. Manufactured by American Health Packaging.*
FDA Label Image

Ahp16801

Ahp16801
Aripiprazole 5 mg oral tablet, oval-shaped and light blue in color. One side is imprinted with the letter 'I' and the other side with the numbers '95'. Manufactured by American Health Packaging.*
FDA Label Image

Ahp17901

Ahp17901
Aripiprazole 10 mg oral tablet, pink to light red, oblong with imprint 'I' on one side and '96' on the other. Manufactured by American Health Packaging.*
FDA Label Image

Ahp19121

Ahp19121
Aripiprazole 5 mg oral tablet, round and yellow, imprinted with 'I' on one side and '97' on the other. Manufactured by American Health Packaging, this tablet is a human prescription drug used for various indications.*
FDA Label Image

Ahp20221

Ahp20221
Aripiprazole tablet round, white, scored, imprinted with 'I' on one side and '98' on the other side. This oral dosage form is part of the American Health Packaging product line. Strength not specified in the image.*
FDA Label Image

Ahp21321

Ahp21321
Aripiprazole 5 mg oral tablet, round and tan colored, with imprint 'I' on one side and '99' on the other side. Manufactured by American Health Packaging.*
FDA Label Image

Structure-1 (Structure 1)

Structure-1 (Structure 1)
Chemical structure of Aripiprazole, showing its molecular connectivity including dichlorophenyl, piperazine, and quinolinone components. This diagram represents the active ingredient's molecular composition as depicted in the product labeling.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A chart titled 'Effect of Other Drugs on Aripiprazole' showing fold changes and 90% confidence intervals for pharmacokinetic parameters AUC and Cmax of aripiprazole. The chart compares the impact of various inhibitors, inducers, gastric acid blockers, and other drugs relative to a reference without interacting drugs, with values ranging from 0.0 to 3.0 fold change.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A pharmacokinetic chart titled 'Effect of Other Drugs on Aripiprazole' showing the fold change and 90% confidence intervals of Dehydro-Aripiprazole with various interacting drugs. The x-axis represents change relative to reference without interacting drug, ranging from 0 to 3. The y-axis lists drug classes and examples, including CYP3A4 inhibitor ketoconazole, CYP2D6 inhibitor quinidine, CYP3A4 inducer carbamazepine, gastric acid blockers famotidine, and others such as valproate, lithium, and lorazepam. Data points show changes in AUC and Cmax parameters.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A forest plot chart illustrating the effect of Aripiprazole on various other drugs. The x-axis shows the fold change relative to a reference without interacting drug, ranging from 0.5 to 3.0. The y-axis lists different drugs and related pharmacokinetic parameters including CYP2D6 substrates (dextromethorphan), CYP2C9, CYP2C19 substrates (S-warfarin, R-warfarin), omeprazole, lamotrigine, valproate, lithium, lorazepam, and venlafaxine including its metabolites. Each line shows fold change and 90% confidence intervals for parameters like AUC, Cmax, INR, and DMDRP.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
A chart titled 'Aripiprazole Fold Change and 90% CI' displaying pharmacokinetic data for Aripiprazole in special populations. The x-axis shows 'Change Relative to Reference' from 0.5 to 3.0, and the y-axis lists groups based on CYP2D6 metabolizer status, gender, age, hepatic impairment severity, and severe renal impairment. The chart presents AUC and Cmax fold changes with error bars comparing these groups to reference populations.*
FDA Label Image

Figure5 (Figure5)

Figure5 (Figure5)
A pharmacokinetic chart depicting the fold change and 90% confidence intervals of dehydro-aripiprazole levels relative to reference across different variables such as CYP2D6 metabolizer status, gender, age groups, hepatic impairment severity, and severe renal impairment. The x-axis represents the change relative to reference, while the y-axis lists the different factor comparisons with AUC and Cmax values.*
FDA Label Image

Figure6 (Figure6)

Figure6 (Figure6)
A Kaplan-Meier curve chart comparing the proportion of subjects with relapse over days from randomization between Aripiprazole and placebo groups. The x-axis represents days from randomization up to 182 days, and the y-axis shows the proportion with relapse. The chart includes numbers of subjects at risk over time for both groups.*
FDA Label Image

Figure7 (Figure7)

Figure7 (Figure7)
A Kaplan-Meier curve showing the proportion of subjects experiencing relapse over days from randomization, comparing Aripiprazole and placebo groups. The x-axis represents days from randomization and the y-axis shows the proportion with relapse. The chart includes the number of subjects at risk for both groups at multiple time points, with Aripiprazole indicated by a solid line and placebo by a dashed line.*
FDA Label Image

Figure8 (Figure8)

Figure8 (Figure8)
A Kaplan-Meier curve chart comparing the proportion of subjects with a relapse over time between Aripiprazole and placebo groups. The x-axis shows days from randomization, and the y-axis shows the proportion with relapse. A table below indicates the number of subjects at risk at various time points for both groups.*
FDA Label Image

Figure9 (Figure9)

Figure9 (Figure9)
A line graph showing the least-squares mean change in YGTSS total TIC score from baseline over 8 weeks of treatment. The graph compares three groups: Abilify Low dose, Abilify High dose, and Placebo, illustrating their respective score changes over time.*
FDA Label Image

2 mg Aripiprazole Tablets Carton (Image 01)

2 mg Aripiprazole Tablets Carton (Image 01)
Label for Aripiprazole tablets USP 2 mg by American Health Packaging. The label indicates a bottle containing 30 tablets (3 blister packs of 10) for oral use, prescription only. It includes NDC 60687-157-21, pharmacist instructions to dispense with medication guide, storage conditions, and distributor information. A QR code for medication guide and prescribing information is also visible.*
FDA Label Image

2 mg Aripiprazole Tablets Carton 2x10 (Image 02)

2 mg Aripiprazole Tablets Carton 2x10 (Image 02)
Aripiprazole 2 mg oral tablets label by American Health Packaging. The label states the product name, strength, dosage form, exact count of 20 tablets packaged as 2 x 10, and usage notes for pharmacists and storage temperature guidelines. It includes barcodes, a QR code for medication guide and prescribing information, and distributor details in Columbus, Ohio.*
FDA Label Image

2 mg Aripiprazole Tablet Blister (Image 03)

2 mg Aripiprazole Tablet Blister (Image 03)
Packaging label for Aripiprazole Tablet, USP 2 mg, supplied by American Health Packaging. The label includes the drug name, dosage strength, tablet form, lot number 123456, expiry date 05/17, and a barcode. The label is repeated multiple times on the sheet, indicating individual tablet unit labels.*
FDA Label Image

5 mg Aripiprazole Tablets Carton (Image 04)

5 mg Aripiprazole Tablets Carton (Image 04)
Aripiprazole Tablets USP 5 mg oral tablets label by American Health Packaging. The label indicates a bottle containing 100 tablets (10x10) with the NDC 60687-168-01. It includes dispensing instructions for pharmacists, storage conditions, a QR code for medication guide and prescribing information, and mentions distribution by American Health Packaging, Columbus, Ohio.*
FDA Label Image

5 mg Aripiprazole Tablets Carton 5x10 (Image 05)

5 mg Aripiprazole Tablets Carton 5x10 (Image 05)
Label for Aripiprazole Tablets USP, 5 mg strength, in a bottle containing 50 tablets (5 strips of 10). The label indicates prescription use only and includes NDC 60687-168-65, barcode, storage instructions, and distributor information for American Health Packaging, Columbus, Ohio.*
FDA Label Image

5 mg Aripiprazole Tablet Blister (Image 06)

5 mg Aripiprazole Tablet Blister (Image 06)
Aripiprazole 5 mg oral tablet labels from American Health Packaging. Each label includes the product name, strength (5 mg), dosage form (tablet, USP), lot number 123456, and expiration date 03/17. The labels display barcodes and the American Health Packaging address in Columbus, OH.*
FDA Label Image

10 mg Aripiprazole Tablets Carton (Image 07)

10 mg Aripiprazole Tablets Carton (Image 07)
Label for Aripiprazole Tablets USP, 10 mg strength, packaged as 100 tablets (10 x 10) for oral use. The label identifies the National Drug Code (NDC) 60687-179-01 and states it is Rx only. It includes storage instructions, pharmacist dispensing guidance, and distributor information for American Health Packaging, Columbus, Ohio. A barcode and QR code for medication guides and prescribing information are visible.*
FDA Label Image

10 mg Aripiprazole Tablets Carton 5x10 (Image 08)

10 mg Aripiprazole Tablets Carton 5x10 (Image 08)
Label for Aripiprazole Tablets, USP 10 mg oral tablets by American Health Packaging. The package contains 50 tablets (5 blister packs of 10 tablets). The label includes prescription and storage information, cautions about blister integrity, mentions the drug is from Camber Pharmaceuticals, and provides a QR code for the medication guide and prescribing information.*
FDA Label Image

10 mg Aripiprazole Tablet Blister (Image 09)

10 mg Aripiprazole Tablet Blister (Image 09)
Aripiprazole Tablet, USP 10 mg label from American Health Packaging, showing multiple identical labels with lot number 123456 and expiry date 05/17. The labels include the product name, strength, dosage form, manufacturer information, and a barcode, arranged in two columns on a single sheet.*
FDA Label Image

15 mg Aripiprazole Tablets Carton (Image 10)

15 mg Aripiprazole Tablets Carton (Image 10)
Label for Aripiprazole Tablets, USP 15 mg, oral tablets in a package of 30 tablets (3 blister cards of 10 tablets each). The label shows the NDC 60687-191-21 and states it is for prescription use only. It includes storage instructions, a pharmacist dispensing instruction, and a QR code for the medication guide and prescribing information. Distributed by American Health Packaging.*
FDA Label Image

15 mg Aripiprazole Tablets Carton 2x10 (Image 11)

15 mg Aripiprazole Tablets Carton 2x10 (Image 11)
Aripiprazole 15 mg oral tablets label showing 20 tablets (2 x 10) packaged by American Health Packaging. The label includes the National Drug Code (NDC) 60687-191-94 and states the medication is prescription-only. Storage instructions specify 20° to 25°C with permitted excursions. The label also advises dispensing a Medication Guide to patients and includes distributor information and a QR code for current Medication Guide and Prescribing Information.*
FDA Label Image

15 mg Aripiprazole Tablet Blister (Image 12)

15 mg Aripiprazole Tablet Blister (Image 12)
Aripiprazole Tablet USP 15 mg oral tablet labels with lot number 123456 and expiry date 05/17. The labels include the product name, strength, dosage form, lot number, expiration date, barcodes, and manufacturer information for American Health Packaging.*
FDA Label Image

20 mg Aripiprazole Tablets Carton (Image 13)

20 mg Aripiprazole Tablets Carton (Image 13)
Label for Aripiprazole Tablets USP 20 mg, containing 30 tablets (3 x 10), labeled for oral use. The label shows the NDC 60687-202-21 and indicates the product is provided by American Health Packaging. The label includes storage instructions, pharmacist dispensing guidance, and a barcode with a QR code for the current Medication Guide and Prescribing Information.*
FDA Label Image

20 mg Aripiprazole Tablets Carton 2x10 (Image 14)

20 mg Aripiprazole Tablets Carton 2x10 (Image 14)
Aripiprazole 20 mg oral tablets label by American Health Packaging. The label indicates a package size of 20 tablets (2 blisters of 10 tablets each). It includes storage instructions, usual dosage reference, and pharmacist dispensing information. The NDC number is 60687-202-94, and the label features a QR code for medication guide and prescribing information.*
FDA Label Image

20 mg Aripiprazole Tablet Blister (Image 15)

20 mg Aripiprazole Tablet Blister (Image 15)
Aripiprazole 20 mg tablet label from American Health Packaging. The label includes dosage strength (20 mg), tablet form, lot number 123456, and expiration date 05/17. The label also features a barcode and states the product is for oral use.*
FDA Label Image

30 mg Aripiprazole Tablets Carton (Image 16)

30 mg Aripiprazole Tablets Carton (Image 16)
Label for Aripiprazole 30 mg oral tablets, USP, manufactured by American Health Packaging. The label indicates a package containing 30 tablets (3 bottles of 10 tablets each). It includes NDC 60687-213-21, dosage strength 30 mg, and a note for pharmacists to dispense with a medication guide. Storage instructions and a QR code for medication guide and prescribing information are also shown.*
FDA Label Image

30 mg Aripiprazole Tablets Carton 2x10 (Image 17)

30 mg Aripiprazole Tablets Carton 2x10 (Image 17)
Label for Aripiprazole Tablets, USP 30 mg oral tablets by American Health Packaging. The package contains 20 tablets (2 blister packs of 10). The label includes NDC 60687-213-94, storage instructions, pharmacist dispensing guidance, and a QR code for medication guide and prescribing information.*
FDA Label Image

30 mg Aripiprazole Tablet Blister (Image 18)

30 mg Aripiprazole Tablet Blister (Image 18)
Packaging label for Aripiprazole Tablet USP 30 mg oral tablets from American Health Packaging. The label includes the product name, strength (30 mg), dosage form (tablet), lot number 123456, and expiry date 05/17. Multiple identical labels are shown in a grid layout, each containing a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.